Qiagen N.V. operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Qiagen N.V. with three other
pharmaceutical manufacturers in Europe:
Vifor Pharma AG
sales of 1.58 billion Swiss Francs [US$1.57 billion]
of which 100%
Krka DD Novo Mesto
(1.33 billion Euro [US$1.50 billion]
based in Italy
(1.35 billion Euro [US$1.53 billion]
Qiagen N.V. reported sales of 1.27 billion Euro (US$1.44 billion)
December of 2018.
increase of 2.4%
versus 2017, when the company's sales were 1.24 billion Euro.
Sales at Qiagen N.V. have increased during each of the previous five years
(and since 2013, sales have increased a total of 30%).